CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to REC.MI

Pasireotide Diaspartate

Phase 2
Recordati S.p.A. (REC.MI)

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Oct '26
REC.MIPhase 2
✓Completed

Pasireotide Diaspartate Phase 2 Est. Readout (PASIPHY)

Pasireotide Diaspartate
Oct 2026~
CT.gov
Competitive Landscape

0 competitors in Post-Bariatric Hypoglycemia

View Full Landscape
Drug Information

Target Indication

Post-Bariatric Hypoglycemia

Clinical Trial

NCT05928390

Last updated: 6/28/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.